ICICI Securities Recommends Buying Abbott India, Sets Rs 33,500 Target
ICICI Securities cited Abbott India’s 11% year-over-year revenue growth in Q2FY27 and said its core brands continue to grow 15–17%.
ICICI Securities cited Abbott India’s 11% year-over-year revenue growth in Q2FY27 and said its core brands continue to grow 15–17%.